Results 31 to 40 of about 15,976 (198)

Long-Term Outcomes of High-Dose Conbercept Treatment for Myopic Choroidal Neovascularization and Idiopathic Choroidal Neovascularization [PDF]

Ophthalmic Research, 2023
Introduction: The aim of the study was to report 2-year outcomes of intravitreal injection of high-dose conbercept (1 mg 2 + PRN scheme) for subjects with myopic choroidal neovascularization (mCNV) and idiopathic choroidal neovascularization (iCNV) by ...
Wei Zhu, Yanlei Hao, Zhongfang Yuan, Huang Chun-mei, Jiehui Liu, Yan Ma   +5 more
openalex   +2 more sources

Vascular endothelial growth factor inhibitors for predominantly Caucasian myopic choroidal neovascularization: 2-year treatment outcomes in clinical practice: data from the Fight Retinal Blindness! Registry. [PDF]

Acta Ophthalmol, 2022
Gabrielle PH, Nguyen V, Creuzot-Garcher C, Miguel L, Alforja S, Sararols L, Casaroli-Marano RP, Zarranz-Ventura J, Gillies M, Arnold J, Barthelmes D.   +10 more
europepmc   +3 more sources

One-Year Outcome of Intravitreal Injection of Ranibizumab Biosimilar for Myopic Choroidal Neovascularization in Japanese Patients. [PDF]

J Clin Med
Objectives: To evaluate the one-year outcomes of intravitreal ranibizumab biosimilar (RBZ-BS) injections for myopic choroidal neovascularization (mCNV) in Japanese patients.
Tomita M, Yamamoto M, Hirayama K, Kyo A, Misawa N, Kinari G, Kohno T, Honda S.   +7 more
europepmc   +2 more sources

Prospective Study Comparing Quantitative Self-Monitoring Metamorphopsia Measurement Tools in Myopic Choroidal Neovascularization (mCNV). [PDF]

Clin Ophthalmol, 2023
Purpose To assess the ability of two self-monitoring digital devices to detect metamorphopsia in myopic choroidal neovascularization (mCNV) and compare their usability.
Hoffmann L, Müller S, Bachmann LM, Claessens D, Hatz K.   +4 more
europepmc   +2 more sources

Prediction of Visual Acuity in Pathologic Myopia with Myopic Choroidal Neovascularization Treated with Anti-Vascular Endothelial Growth Factor Using a Deep Neural Network Based on Optical Coherence Tomography Images. [PDF]

Biomedicines, 2023
Myopic choroidal neovascularization (mCNV) is a common cause of vision loss in patients with pathological myopia. However, predicting the visual prognosis of patients with mCNV remains challenging.
Yang M, Han J, Park JI, Hwang JS, Han JM, Yoon J, Choi S, Hwang G, Hwang DD.   +8 more
europepmc   +2 more sources

COMPARISON OF CHARACTERISTICS AND TREATMENT OUTCOMES OF TYPE 1 AND TYPE 2 MYOPIC CHOROIDAL NEOVASCULARIZATION AFTER ANTIVASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY. [PDF]

Retina
This study compares baseline characteristics and treatment outcomes of Type 1 and Type 2 myopic choroidal neovascularization after antivascular endothelial growth factors therapy, highlighting significant visual improvements in both types and identifying
Tew TB, Hsieh YT, Tsui MC, Hsia Y, Lee CY, Wang SW, Huang CJ, Ma IH, Hung KC, Lai TT, Yang CH, Yang CM, Ho TC.   +12 more
europepmc   +2 more sources

Correlation between AI-measured lacquer cracks extension and development of myopic choroidal neovascularization. [PDF]

Eye (Lond), 2023
To investigate the correlation between the AI-measured area of the lacquer cracks (LC) at their first detection and the occurrence of a choroidal neovascularization (CNV) during the follow-up in patients affected by pathologic myopia.
Crincoli E, Ferrara S, Miere A, Sacconi R, Battista M, Catania F, Souied EH, Querques G.   +7 more
europepmc   +2 more sources

Systemic Oxidative Stress Level as a Pathological and Prognostic Factor in Myopic Choroidal Neovascularization. [PDF]

Ophthalmol Sci
Wang J, Kunikata H, Yasuda M, Himori N, Nitta F, Nakazawa T.   +5 more
europepmc   +2 more sources

Myopic choroidal neovascularization with neovascular signal around perforating scleral vessel prone to recur after anti-VEGF therapy. [PDF]

Eye Vis (Lond)
To compare the recurrence of myopic choroidal neovascularization (mCNV) based on the neovascular signal of mCNV around the perforating scleral vessel (PSV).
She X, Yao W, Huang G, Liang Z, Xie J, Tao J, Wu S, Mao J, Chen Y, Zhang Y, Shen L.   +10 more
europepmc   +2 more sources

Long-term Outcomes of Myopic Choroidal Neovascularization and Retinal Changes according to ATN Classification [PDF]

Journal of the Korean Ophthalmological Society, 2023
Purpose: To evaluate the clinical outcomes of myopic choroidal neovascularization (CNV) and atrophic and tractional changes according to the ATN (A: atrophy, T: traction, N: neovascularization) classification system.Methods: This was a retrospective ...
S. W. Yeo, Jong‐Min Kim
openalex   +2 more sources